Blog

FDA Fast Tracks TME Pharma’s Glioblastoma Treatment
💊 TME Pharma's NOX-A12 gets FDA Fast Track for glioblastoma, aiming to expedite the review and approval process. 🎯

Forbion Joins Oversubscribed US Financing Rounds
🇪🇺🚀 European VC firm Forbion joins oversubscribed US financing rounds for Capstan Therapeutics and Engrail Therapeutics 🌍💰 LifeSciences

Revolutionary Biofuel Breakthrough: $6M Funding Fuels Terragia’s Low-Carbon Tech
Terragia Biofuel raises $6 million to develop low-carbon biofuel technology 🌍🔬💰🌱🚀👥

Lonza Revolutionizes Respiratory Treatment with Advanced Pulmonary Delivery Services
📢 Lonza expands service offering for spray-dried biologics for pulmonary delivery, improving respiratory therapies and patient access. 🌬️💊🌍💪

Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies
🔍 Monoclonal antibodies (mAbs) have paved the way for advanced therapies, thanks to decades of development and manufacturing improvements. 💪

FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!
📢 The FDA published new guidance for CAR-T cell products, covering change management, risk assessment, flow cytometry, and more. 👩🔬🔬🧪🗂 CAR-T FDA

Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!
🤖🔬 Researchers suggest that robots and AI can address manufacturing challenges in cell and gene therapy. ⬆️🌍 The industry is growing rapidly, requiring skilled personnel and increased production. 🤖🔬 Automation and AI can improve efficiency and reduce costs.

Gut Bacteria: The Hidden Culprits Behind Autoimmune Kidney Diseases?
📢 New study reveals how gut bacteria may trigger autoimmune diseases in kidneys by leaking antigens, activating immune system. 🦠💉







